Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human engineered monoclonal antibody specific for Transforming Growth Factor 2

EU orphan designation number: EU/3/01/042
Active ingredient: Human engineered monoclonal antibody specific for Transforming Growth Factor 2
Indication: Prevention of scarring in glaucoma filtration surgical procedures
Sponsor: Cambridge Antibody Technology
Milstein Building, Granta Park, Cambridge CB1 6GH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/05/2001 Centralised Orphan - Designation EMEA/OD/070/00 (2001)1505 of 30/05/2001
18/06/2009 Centralised Orphan - Removal of orphan designation from Community Register